Patrys Ltd's (ASX:PAB) shares have continued to rally during the trading day, and are now up 200% at $0.012, with over 84 million shares changing hands.
That means Patrys isn't just one of the most active today, but also the best performer.
The market attention followed positive pre-clinical data for its lead drug candidate PAT-DX1, a novel first-in-class drug candidate being developed to treat a range of different cancers.
Studies in multiple pre-clinical models of cancer have demonstrated the ability of Patrys’ proprietary humanized antibody, PAT-DX1 to be taken-up and to kill cancer cells.
This confirms the successful humanization and de-immunization of 3E10-derived antibody fragments with conserved structural properties and enhanced in vitro activity.
Company Name · Code · Last · Change · Volume
Pancontinental Oil & Gas NL · PCL · $0.004 · 33.33% · 177,014,965
Patrys Ltd · PAB · $0.012 · 200% · 83,199,936
Magnum Gas & Power · MPE · $0.002 · 0% · 64,351,525
Lynas Corporation Ltd · LYC · $0.195 · 0% · 60,070,170
Valor Resources Ltd · VAL · $0.032 · 18.52% · 41,413,610
Pure Minerals Ltd · PM1 · $0.024 · 14.29% · 24,448,949
Pacifico Minerals Ltd · PMY · $0.007 · 16.67% · 24,322,930
Clancy Exploration Ltd · CLY · $0.003 · 50% · 19,438,150
South32 Ltd · S32 · $3.170 · -1.86% · 18,912,477
ResApp Health Ltd · RAP · $0.076 · -10.59% · 15,150,421